A new species of the spittlebug genus \u3ci\u3eClastoptera\u3c/i\u3e Germar (Hemiptera: Cercopoidea: Clastopteridae) on Florida oaks

Over the past decade, a previously unrecorded spittlebug of the genus Clastoptera Germar (Hemip­tera: Cercopoidea: Clastopteridae) has been observed in abundance on oaks (Quercus L. spp., Fagaceae) in several Florida counties. We describe this spittlebug as a new species, Clastoptera querci Thompson, Halbert and Rothschild, new species, provide information on its life history, host plants and distribution, and place it in the context of other members of the genus. Clastoptera spp. can transmit Xylella fastidiosa Wells et al., a bacterial pathogen that causes bacterial leaf scorch associated with oak decline. Thus C. querci should be monitored as a possible vector of X. fastidiosa in oaks

High Quality Audio Coding with MDCTNet

We propose a neural audio generative model, MDCTNet, operating in the perceptually weighted domain of an adaptive modified discrete cosine transform (MDCT). The architecture of the model captures correlations in both time and frequency directions with recurrent layers (RNNs). An audio coding system is obtained by training MDCTNet on a diverse set of fullband monophonic audio signals at 48 kHz sampling, conditioned by a perceptual audio encoder. In a subjective listening test with ten excerpts chosen to be balanced across content types, yet stressful for both codecs, the mean performance of the proposed system for 24 kb/s variable bitrate (VBR) is similar to that of Opus at twice the bitrate.Comment: Five pages, five figure

VCAM-1-targeted MRI Improves Detection of the Tumor-brain Interface

PurposeDespite optimal local therapy, tumor cell invasion into normal brain parenchyma frequently results in recurrence in patients with solid tumors. The aim of this study was to determine whether microvascular inflammation can be targeted to better delineate the tumor-brain interface through vascular cell adhesion molecule-1 (VCAM-1)-targeted MRI.Experimental designIntracerebral xenograft rat models of MDA231Br-GFP (breast cancer) brain metastasis and U87MG (glioblastoma) were used to histologically examine the tumor-brain interface and to test the efficacy of VCAM-1-targeted MRI in detecting this region. Human biopsy samples of the brain metastasis and glioblastoma margins were examined for endothelial VCAM-1 expression.ResultsThe interface between tumor and surrounding normal brain tissue exhibited elevated endothelial VCAM-1 expression and increased microvessel density. Tumor proliferation and stemness markers were also significantly upregulated at the tumor rim in the brain metastasis model. T2*-weighted MRI, following intravenous administration of VCAM-MPIO, highlighted the tumor-brain interface of both tumor models more extensively than gadolinium-DTPA-enhanced T1-weighted MRI. Sites of VCAM-MPIO binding, evident as hypointense signals on MR images, correlated spatially with endothelial VCAM-1 upregulation and bound VCAM-MPIO beads detected histologically. These findings were further validated in an orthotopic medulloblastoma model. Finally, the tumor-brain interface in human brain metastasis and glioblastoma samples was similarly characterized by microvascular inflammation, extending beyond the region detectable using conventional MRI.ConclusionsThis work illustrates the potential of VCAM-1-targeted MRI for improved delineation of the tumor-brain interface in both primary and secondary brain tumors

'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study

Background: \u27MRI negative PET positive temporal lobe epilepsy\u27 represents a substantial minority of temporal lobe epilepsy (TLE). Clinicopathological and qualitative imaging differences from mesial temporal lobe epilepsy are reported. We aimed to compare TLE with hippocampal sclerosis (HS+ve) and non lesional TLE without HS (HS-ve) on MRI, with respect to quantitative FDG-PET and MRI measures.Methods: 30 consecutive HS-ve patients with well-lateralised EEG were compared with 30 age- and sex-matched HS+ve patients with well-lateralised EEG. Cerebral, cortical lobar and hippocampal volumetric and co-registered FDG-PET metabolic analyses were performed.Results: There was no difference in whole brain, cerebral or cerebral cortical volumes. Both groups showed marginally smaller cerebral volumes ipsilateral to epileptogenic side (HS-ve 0.99, p = 0.02, HS+ve 0.98, p &lt; 0.001). In HS+ve, the ratio of epileptogenic cerebrum to whole brain volume was less (p = 0.02); the ratio of epileptogenic cerebral cortex to whole brain in the HS+ve group approached significance (p = 0.06). Relative volume deficits were seen in HS+ve in insular and temporal lobes. Both groups showed marked ipsilateral hypometabolism (p &lt; 0.001), most marked in temporal cortex. Mean hypointensity was more marked in epileptogenic-to-contralateral hippocampus in HS+ve (ratio: 0.86 vs 0.95, p &lt; 0.001). The mean FDG-PET ratio of ipsilateral to contralateral cerebral cortex however was low in both groups (ratio: HS-ve 0.97, p &lt; 0.0001; HS+ve 0.98, p = 0.003), and more marked in HS-ve across all lobes except insula.Conclusion: Overall, HS+ve patients showed more hippocampal, but also marginally more ipsilateral cerebral and cerebrocortical atrophy, greater ipsilateral hippocampal hypometabolism but similar ipsilateral cerebral cortical hypometabolism, confirming structural and functional differences between these groups.<br /

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Importance: Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality. // Objective: To evaluate whether systemic anticancer treatments (SACTs), tumor subtypes, patient demographic characteristics (age and sex), and comorbidities are associated with COVID-19 mortality. // Design, Setting, and Participants: The UK Coronavirus Cancer Monitoring Project (UKCCMP) is a prospective cohort study conducted at 69 UK cancer hospitals among adult patients (≥18 years) with an active cancer and a clinical diagnosis of COVID-19. Patients registered from March 18 to August 1, 2020, were included in this analysis. // Exposures: SACT, tumor subtype, patient demographic characteristics (eg, age, sex, body mass index, race and ethnicity, smoking history), and comorbidities were investigated. // Main Outcomes and Measures: The primary end point was all-cause mortality within the primary hospitalization. // Results: Overall, 2515 of 2786 patients registered during the study period were included; 1464 (58%) were men; and the median (IQR) age was 72 (62-80) years. The mortality rate was 38% (966 patients). The data suggest an association between higher mortality in patients with hematological malignant neoplasms irrespective of recent SACT, particularly in those with acute leukemias or myelodysplastic syndrome (OR, 2.16; 95% CI, 1.30-3.60) and myeloma or plasmacytoma (OR, 1.53; 95% CI, 1.04-2.26). Lung cancer was also significantly associated with higher COVID-19–related mortality (OR, 1.58; 95% CI, 1.11-2.25). No association between higher mortality and receiving chemotherapy in the 4 weeks before COVID-19 diagnosis was observed after correcting for the crucial confounders of age, sex, and comorbidities. An association between lower mortality and receiving immunotherapy in the 4 weeks before COVID-19 diagnosis was observed (immunotherapy vs no cancer therapy: OR, 0.52; 95% CI, 0.31-0.86). // Conclusions and Relevance: The findings of this study of patients with active cancer suggest that recent SACT is not associated with inferior outcomes from COVID-19 infection. This has relevance for the care of patients with cancer requiring treatment, particularly in countries experiencing an increase in COVID-19 case numbers. Important differences in outcomes among patients with hematological and lung cancers were observed

A new species of the spittlebug genus \u3ci\u3eClastoptera\u3c/i\u3e Germar (Hemiptera: Cercopoidea: Clastopteridae) on Florida oaks

Over the past decade, a previously unrecorded spittlebug of the genus Clastoptera Germar (Hemip­tera: Cercopoidea: Clastopteridae) has been observed in abundance on oaks (Quercus L. spp., Fagaceae) in several Florida counties. We describe this spittlebug as a new species, Clastoptera querci Thompson, Halbert and Rothschild, new species, provide information on its life history, host plants and distribution, and place it in the context of other members of the genus. Clastoptera spp. can transmit Xylella fastidiosa Wells et al., a bacterial pathogen that causes bacterial leaf scorch associated with oak decline. Thus C. querci should be monitored as a possible vector of X. fastidiosa in oaks

A new species of the spittlebug genus Clastoptera Germar (Hemiptera: Cercopoidea: Clastopteridae) on Florida oaks

Over the past decade, a previously unrecorded spittlebug of the genus Clastoptera Germar (Hemiptera: Cercopoidea: Clastopteridae) has been observed in abundance on oaks (Quercus L. spp., Fagaceae) in several Florida counties. We describe this spittlebug as a new species, Clastoptera querci Thompson, Halbert and Rothschild, new species, provide information on its life history, host plants and distribution, and place it in the context of other members of the genus. Clastoptera spp. can transmit Xylella fastidiosa Wells et al., a bacterial pathogen that causes bacterial leaf scorch associated with oak decline. Thus C. querci should be monitored as a possible vector of X. fastidiosa in oaks